Publications:  Miss Michela Borghesan

Pazienza V, Panebianco C, Rappa F, Memoli D, Borghesan M, Cannito S, Oji A, Mazza G et al.(2016). Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis. Epigenetics Chromatin vol. 9, 45-45.

Borghesan M, Fusilli C, Rappa F, Panebianco C, Rizzo G, Oben JA, Mazzoccoli G, Faulkes C et al.(2016). DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression. Cancer Res vol. 76, (3) 594-606.

Borghesan M, Mazzoccoli G, Sheedfar F, Oben J, Pazienza V, Vinciguerra M(2014). Histone variants and lipid metabolism. Biochem Soc Trans vol. 42, (5) 1409-1413.

Borghesan M, Mazza T, Fusilli C, Faulkes C, Pazienza V, Vinciguerra M (2014). HISTONE VARIANT macroH2A1 PROTECTS AGAINST 5-AZA-2 '-DEOXYCYTIDINE INDUCED HEPATOCYTE SENESCENCE. JOURNAL OF HEPATOLOGY. vol. 60, S100-S100.

Mazzoccoli G, Tevy MF, Borghesan M, Delle Vergini MR, Vinciguerra M(2014). Caloric restriction and aging stem cells: the stick and the carrot?. Exp Gerontol vol. 50, 137-148.

Pazienza V, Borghesan M, Mazza T, Sheedfar F, Panebianco C, Williams R, Mazzoccoli G, Andriulli A et al.(2014). SIRT1-metabolite binding histone macroH2A1.1 protects hepatocytes against lipid accumulation. Aging (Albany NY) vol. 6, (1) 35-47.

Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M(2013). Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). Curr Pharm Des vol. 19, (15) 2737-2746.

Vinciguerra M, Borghesan M, Pazienza V, Piepoli A, Palmieri O, Tarquini R, Tevy MF, De Cata A et al.(2013). The transcriptional regulators, the immune system and the the circadian clock. J Biol Regul Homeost Agents vol. 27, (1) 9-22.